AKTS
Ticker
Aktis Oncology, Inc.
AKTS · Healthcare · Aktis Oncology, Inc., a clinical-stage oncology company, engages in the research, development, and commercialization of targeted radiopharm…Aktis Oncology, Inc. (AKTS), in the Healthcare sector, has 8 disclosed filings on Paydirt over the trailing twelve months from 8 corporate insiders: 6 purchases and 2 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Jul 8 and filed Jul 10. The most active filer was Akos Czibere with 1 filing.
Add to watchlistFilings, ttm
8
6 buys · 2 sells
Traders, ttm
8
8 insiders
Volume, ttmiDollar value disclosed in the window
$117.1M
estimated for Congress, as filed for insiders
Median delay
2d
execution to disclosure
Last traded
Jul 8
Filed Jul 10
ADViAverage daily dollar volume
$8.9M
market data
Share price · 12M
$25.98 (+16.0%)
Adjusted for splits and dividends.
Volume by month
Buys $114.3M
Sells $2.8M
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed
ACRecent filings
Shulamit Ron-BiggerSALE
Chief Operating Officer
$1.4M50,000 sh across 3 lots
Exec Jul 8
Filed Jul 10 · 6:11 AM ET Akos CzibereSALE Chief Medical Officer $1.4M
50,000 sh across 3 lots
Exec Jul 8
Filed Jul 10 · 6:10 AM ET Todd FoleyPURCHASE Director $4.2M
232,870 sh × $18.00
Exec Jan 12
Filed Jan 14 · 6:20 PM ET Mpm Bioventures 2018, L.P.PURCHASE 10% owner $20.0M
1,112,777 sh × $18.00
Exec Jan 12
Filed Jan 14 · 6:19 PM ET Ansbert GadickePURCHASE 10% owner $20.0M
1,112,777 sh × $18.00
Exec Jan 12
Filed Jan 14 · 6:17 PM ET EcoR1 Capital, LLCPURCHASE Director $40.0M
2,222,222 sh across 2 lots
Exec Jan 12
Filed Jan 12 · 8:28 PM ET Vida Ventures II, LLCPURCHASE 10% owner $15.0M
835,000 sh across 2 lots
Exec Jan 12
Filed Jan 12 · 5:10 PM ET Helen Susan KimPURCHASE Director $15.0M
835,000 sh across 2 lots
Exec Jan 12
Filed Jan 12 · 5:00 PM ET